the feminist critique of science

joy frestedt frest001 at MAROON.TC.UMN.EDU
Tue Sep 12 10:23:09 EST 1995

Actually, many reports do exist which study RARE men with breast cancer.  I'm 
most familiar with the cytogenetic studies but drug studies, etc. are also 
present.  (flame retardant: I never said these weren't worth studying!)
==========from Pearse========
In message <43458k$gdq at> Drmarts writes:
> In message <wardp-1109951514250001 at>, wardp at
> (Pearse Ward) writes:
>snip>>> The studies referred to as
> being all male were mostly studies done in lab. animals (inbred strains of
> mice). Selecting one sex was simply one more method for removing
> confounding variables, and male mice happen to be less valuable.  Most
> studies done in humans choose sample populations suitable to the study.<<<
========from Sherry=======
> What you seem to have a hard time believing is that many important
> clinical trilas did exclude women (the most well known example being the
> aspirin and heart disease prevention trial, which was done on a group of
> male physicians), and even though the results should not have been
> extrapolated to women and children, they often were and still are. I'm
> particularly  of clinical trials of new drugs. The reasoning? Women have
> menstrual cycles, and the cyclical hormonal changes would be a
> "confounding variable." Of course, menstruating women would be taking the
> drug/using the treatment, but that never seemed a good enough reason for
> including them. (BTW, children are used in clinical trials for drug
> approvals due to ethical concerns re: informed consent) I tend to agree
> with Muriel that the regulations forcing inclusion of women in clinical
> trials did represent a new way of thinking about how such trials should be
> done, and how the results should be interepreted. I served on an
> Institutional Review Board (reviews protocols involving human subjects) at
> the time the new regulations were being proposed, and you would have been
> amazed at the objections that were raised by researchers who wanted to
> keep clinical trials male-only. At times I was beginning to think that if
> they could have figured out a way to do clinical trials for breast or
> uterine or cervical cancer on men they would have done it!

> Sherry Marts
> American Health Assistance Foundation

More information about the Womenbio mailing list